We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Based primarily from its Washington DC office, Linklaters LLP‘s main focus in the securities litigation field is defending senior executives at public companies across a range of alleged securities fraud violations. Many of these are government initiated civil and/or criminal investigations/enforcement actions, where the firm is particularly well-placed to advise, in part due to the preponderance of former government agency officials among its ranks. Formerly at the DOJ, team head Adam Lurie is particularly skilled at advising on white-collar-related securities matters, including defending senior executives against insider trading charges. Ex-SEC lawyer Doug Davison is also a key member of the team, regularly working alongside Lurie when there is an SEC-initiated component.
Legal 500 Editorial commentary
Key clients
- Stephen Bond-Nelson, a former Managing Director and Portfolio Manager at Allianz Global Investors U.S. LLC
- Macquarie Investment Management Business Trust
Work highlights
- Represent Stephen Bond-Nelson, a former Managing Director and Portfolio Manager at Allianz Global Investors U.S. LLC (AGI), in DOJ and SEC actions involving losses suffered by AGI’s Structured Alpha unit in and around March 2020 at the beginning of the COVID-19 pandemic. The government actions allege that Mr. Bond-Nelson, together with others, engaged in certain fraudulent and deceptive conduct in connection with the offer, purchase and sale of Structured Alpha funds.
- The firm represents Dr. Nader Pourhassan, the former CEO of a publicly traded biotechnology company, CytoDyn, Inc, in both civil and criminal actions brought by the SEC and the DOJ in the District of Maryland. The respective actions are related to allegations of securities fraud and insider trading during Dr. Pourhassan’s tenure as CEO at CytoDyn.